Skip to main content
Top
Published in: AIDS and Behavior 7/2017

01-07-2017 | Original Paper

Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care

Authors: Aaron M. Kipp, Peter F. Rebeiro, Bryan E. Shepherd, Lauren Brinkley-Rubinstein, Megan Turner, Sally Bebawy, Timothy R. Sterling, Todd Hulgan

Published in: AIDS and Behavior | Issue 7/2017

Login to get access

Abstract

We assessed the association between marijuana use and retention in HIV care through a retrospective cohort study of patients engaged in care at a large HIV clinic in 2011 and 2012. Two different retention outcomes were assessed: not meeting the Institute of Medicine’s (IOM) retention definition (≥2 provider visits ≥90 days apart in a calendar year) and no-show visits. Any marijuana use and frequency of marijuana use were obtained from a substance use screening questionnaire administered at each clinic visit. Modified Poisson regression was used to estimate risk ratios and 95% confidence intervals for the association between marijuana use and retention outcomes. Marijuana use was reported by 17% of 1791 patients and 21% were not retained (IOM definition). Marijuana use was not associated with the IOM retention outcome, but was associated with missing the next scheduled appointment. A non-linear dose–response was observed for frequency of marijuana use and missed visits, with daily users having the highest risk compared to non-users. Daily marijuana use had a negative impact on HIV clinic attendance. Further research is needed to elucidate the mechanisms by which marijuana use affects this outcome to inform targeted interventions.
Literature
2.
go back to reference Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. HHS Publication No. SMA 16-4984, NSDUH Series H-51. Rockville, MD: Substance Abuse and Mental Health Services Adminstration. 2016. http://www.samhsa.gov/data. Accessed Nov 2016. Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. HHS Publication No. SMA 16-4984, NSDUH Series H-51. Rockville, MD: Substance Abuse and Mental Health Services Adminstration. 2016. http://​www.​samhsa.​gov/​data. Accessed Nov 2016.
3.
go back to reference Kipp AM, Desruisseau AJ, Qian HZ. Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. J Subst Abuse Treat. 2011;40(4):386–96.CrossRefPubMedPubMedCentral Kipp AM, Desruisseau AJ, Qian HZ. Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. J Subst Abuse Treat. 2011;40(4):386–96.CrossRefPubMedPubMedCentral
4.
go back to reference Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2009. Morb Mortal Wkly Rep 2014;63(SS-5):1–22. Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection—Medical Monitoring Project, United States, 2009. Morb Mortal Wkly Rep 2014;63(SS-5):1–22.
5.
go back to reference Allshouse AA, MaWhinney S, Jankowski CM, Kohrt WM, Campbell TB, Erlandson KM. The impact of marijuana use on the successful aging of HIV-infected adults. J Acquir Immune Defic Syndr. 2015;69(2):187–92.CrossRefPubMedPubMedCentral Allshouse AA, MaWhinney S, Jankowski CM, Kohrt WM, Campbell TB, Erlandson KM. The impact of marijuana use on the successful aging of HIV-infected adults. J Acquir Immune Defic Syndr. 2015;69(2):187–92.CrossRefPubMedPubMedCentral
6.
go back to reference Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentral Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentral
7.
go back to reference D’Souza G, Matson PA, Grady CD, et al. Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Study (WIHS) Cohort, 1994–2010. J Acquir Immune Defic Syndr. 2012;61:618–26.CrossRefPubMedPubMedCentral D’Souza G, Matson PA, Grady CD, et al. Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Study (WIHS) Cohort, 1994–2010. J Acquir Immune Defic Syndr. 2012;61:618–26.CrossRefPubMedPubMedCentral
8.
go back to reference Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;371(9):879.PubMed Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;371(9):879.PubMed
9.
go back to reference Van Tieu H, Koblin BA. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS. 2009;4(4):314–8.CrossRefPubMed Van Tieu H, Koblin BA. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS. 2009;4(4):314–8.CrossRefPubMed
10.
go back to reference Kingree JB, Betz H. Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners. Drug Alcohol Depend. 2003;72(2):197–203.CrossRefPubMed Kingree JB, Betz H. Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners. Drug Alcohol Depend. 2003;72(2):197–203.CrossRefPubMed
11.
go back to reference Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556–69.CrossRefPubMed Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556–69.CrossRefPubMed
13.
go back to reference Parolaro D, Vigano D, Realini N, Rubino T. Role of endocannabinoids in regulating drug dependence. Neuropsychiatr Dis Treat. 2007;3(6):711–21.PubMedPubMedCentral Parolaro D, Vigano D, Realini N, Rubino T. Role of endocannabinoids in regulating drug dependence. Neuropsychiatr Dis Treat. 2007;3(6):711–21.PubMedPubMedCentral
14.
go back to reference Corless IB, Lindgren T, Holzemer W, et al. Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res. 2009;18(2):172–93.CrossRefPubMed Corless IB, Lindgren T, Holzemer W, et al. Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res. 2009;18(2):172–93.CrossRefPubMed
15.
go back to reference Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs. 2004;18:215–28.CrossRefPubMed Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs. 2004;18:215–28.CrossRefPubMed
16.
go back to reference Braitstein P, Kendall T, Chan K, et al. Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS. 2001;15:532–3.CrossRefPubMed Braitstein P, Kendall T, Chan K, et al. Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS. 2001;15:532–3.CrossRefPubMed
17.
go back to reference Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manag. 2005;29:358–67.CrossRef Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manag. 2005;29:358–67.CrossRef
18.
go back to reference Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr. 2004;35:38–45.CrossRefPubMed Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr. 2004;35:38–45.CrossRefPubMed
19.
20.
go back to reference Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE. 2010;5(12):e14433.CrossRefPubMedPubMedCentral Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE. 2010;5(12):e14433.CrossRefPubMedPubMedCentral
21.
go back to reference Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–80.CrossRefPubMed Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–80.CrossRefPubMed
22.
go back to reference Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2014;37(1):1–10.CrossRefPubMed Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2014;37(1):1–10.CrossRefPubMed
23.
go back to reference Rosen MI, Black AC, Arnsten JH, et al. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav. 2013;17(1):142–7.CrossRefPubMedPubMedCentral Rosen MI, Black AC, Arnsten JH, et al. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14. AIDS Behav. 2013;17(1):142–7.CrossRefPubMedPubMedCentral
24.
go back to reference de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005;38:43–6.CrossRefPubMed de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005;38:43–6.CrossRefPubMed
25.
go back to reference Ghosn J, Leruez-Ville M, Blanche J, et al. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Clin Infect Dis. 2014;58(12):1763–70.CrossRefPubMed Ghosn J, Leruez-Ville M, Blanche J, et al. HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Clin Infect Dis. 2014;58(12):1763–70.CrossRefPubMed
26.
go back to reference Milloy MJ, Marshall B, Kerr T, et al. High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Review. 2015;34(2):135–40.CrossRefPubMed Milloy MJ, Marshall B, Kerr T, et al. High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Review. 2015;34(2):135–40.CrossRefPubMed
27.
go back to reference Abrams DI, Hilton JF, Leiser RJ, et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003;139(4):258–66.CrossRefPubMed Abrams DI, Hilton JF, Leiser RJ, et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003;139(4):258–66.CrossRefPubMed
28.
go back to reference Rasbach DA, Desruisseau AJ, Kipp AM, et al. Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care. 2013;25(1):109–17.CrossRefPubMed Rasbach DA, Desruisseau AJ, Kipp AM, et al. Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care. 2013;25(1):109–17.CrossRefPubMed
29.
go back to reference Dietz E, Clum GA, Chung SE, et al. Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health. 2010;46(3):278–83.CrossRefPubMed Dietz E, Clum GA, Chung SE, et al. Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health. 2010;46(3):278–83.CrossRefPubMed
30.
go back to reference Weber R, Huber M, Battegay M, et al. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Med. 2015;16(3):137–51.CrossRefPubMed Weber R, Huber M, Battegay M, et al. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Med. 2015;16(3):137–51.CrossRefPubMed
31.
go back to reference Morgan E, Khanna AS, Skaathun B, et al. Marijuana use among young black men who have sex with men and the HIV care continuum: findings from the uConnect Cohort. Subst Use Misuse. 2016;51(13):1751–9.CrossRefPubMed Morgan E, Khanna AS, Skaathun B, et al. Marijuana use among young black men who have sex with men and the HIV care continuum: findings from the uConnect Cohort. Subst Use Misuse. 2016;51(13):1751–9.CrossRefPubMed
32.
go back to reference Ford MA, Spicer CM. Monitoring HIV care in the United States: indicators and data systems. Washington, DC: National Academies Press; 2012. Ford MA, Spicer CM. Monitoring HIV care in the United States: indicators and data systems. Washington, DC: National Academies Press; 2012.
33.
go back to reference Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661–70.CrossRefPubMed Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661–70.CrossRefPubMed
34.
go back to reference Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.CrossRefPubMedPubMedCentral Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.CrossRefPubMedPubMedCentral
35.
go back to reference Mugavero MJ, Westfall AO, Zinski A, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61(5):574–80.CrossRefPubMedPubMedCentral Mugavero MJ, Westfall AO, Zinski A, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61(5):574–80.CrossRefPubMedPubMedCentral
36.
go back to reference Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61(2):164–70.CrossRefPubMedPubMedCentral Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61(2):164–70.CrossRefPubMedPubMedCentral
37.
go back to reference Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.CrossRefPubMedPubMedCentral Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.CrossRefPubMedPubMedCentral
38.
go back to reference Monroe AK, Lau B, Mugavero MJ, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016;73(4):419–25.CrossRefPubMed Monroe AK, Lau B, Mugavero MJ, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016;73(4):419–25.CrossRefPubMed
39.
go back to reference Chitsaz E, Meyer JP, Krishnan A, et al. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013;17(Suppl 2):S118–27.CrossRefPubMed Chitsaz E, Meyer JP, Krishnan A, et al. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013;17(Suppl 2):S118–27.CrossRefPubMed
40.
go back to reference Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis. 2013;57(9):1309–17.CrossRefPubMedPubMedCentral Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis. 2013;57(9):1309–17.CrossRefPubMedPubMedCentral
41.
go back to reference German D, Latkin CA. Social stability and health: exploring multidimensional social disadvantage. J Urban Health. 2012;89(1):19–35.CrossRefPubMed German D, Latkin CA. Social stability and health: exploring multidimensional social disadvantage. J Urban Health. 2012;89(1):19–35.CrossRefPubMed
42.
go back to reference Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16(5):156–61.PubMed Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16(5):156–61.PubMed
43.
go back to reference Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12–6.PubMed Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12–6.PubMed
44.
go back to reference Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;15(31 Suppl 3):S149–53.CrossRef Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;15(31 Suppl 3):S149–53.CrossRef
45.
go back to reference Hightow-Weidman LB, Jones K, Wohl AR, et al. Early linkage and retention in care: findings from the outreach, linkage, and retention in care initiative among young men of color who have sex with men. AIDS Patient Care STDS. 2011;25(Suppl 1):S31–8.CrossRefPubMed Hightow-Weidman LB, Jones K, Wohl AR, et al. Early linkage and retention in care: findings from the outreach, linkage, and retention in care initiative among young men of color who have sex with men. AIDS Patient Care STDS. 2011;25(Suppl 1):S31–8.CrossRefPubMed
46.
go back to reference Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62(10):2420–33.CrossRefPubMed Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62(10):2420–33.CrossRefPubMed
47.
go back to reference Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Int Med. 2016;176(3):352–61.CrossRef Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Int Med. 2016;176(3):352–61.CrossRef
48.
go back to reference Schroder KE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV/AIDS Rep. 2009;6(4):210–6.CrossRefPubMed Schroder KE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV/AIDS Rep. 2009;6(4):210–6.CrossRefPubMed
49.
go back to reference Tucker JA, Simpson CA, Huang J, Roth DL, Stewart KE. Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South. AIDS Patient Care STDS. 2013;27(5):280–6.CrossRefPubMedPubMedCentral Tucker JA, Simpson CA, Huang J, Roth DL, Stewart KE. Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South. AIDS Patient Care STDS. 2013;27(5):280–6.CrossRefPubMedPubMedCentral
50.
go back to reference Shorey RC, Moore TM, McNulty JK, Stuart GL. Do alcohol and marijuana increase the risk for female dating violence victimization? A prospective daily diary investigation. Psychol Violence. 2016;6(4):509–18.CrossRefPubMed Shorey RC, Moore TM, McNulty JK, Stuart GL. Do alcohol and marijuana increase the risk for female dating violence victimization? A prospective daily diary investigation. Psychol Violence. 2016;6(4):509–18.CrossRefPubMed
51.
go back to reference O’Hara RE, Armeli S, Tennen H. Alcohol and cannabis use among college students: substitutes or complements? Addict Behav. 2016;58:1–6.CrossRefPubMed O’Hara RE, Armeli S, Tennen H. Alcohol and cannabis use among college students: substitutes or complements? Addict Behav. 2016;58:1–6.CrossRefPubMed
Metadata
Title
Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care
Authors
Aaron M. Kipp
Peter F. Rebeiro
Bryan E. Shepherd
Lauren Brinkley-Rubinstein
Megan Turner
Sally Bebawy
Timothy R. Sterling
Todd Hulgan
Publication date
01-07-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1716-7

Other articles of this Issue 7/2017

AIDS and Behavior 7/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.